Institute of Biomedical Science, Catholic Kwandong University International St. Mary's Hospital, Incheon 22711, Korea.
Cardiovascular Center, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong-Si 18450, Korea.
Int J Environ Res Public Health. 2020 Dec 21;17(24):9568. doi: 10.3390/ijerph17249568.
(1) Background: Non-alcoholic fatty liver disease (NAFLD) is associated with various cardiometabolic diseases. However, the association between NAFLD and stroke is not well known. The purpose of our study is to reveal the relationship between NAFLD and Stroke incidence. (2) Methods: Using data from a Korean prospective cohort study, we excluded participants with heavy alcohol consumption and a history of stroke; hence, 7964 adults aged 40-69 years were included in this study. According to their fatty liver index (FLI), participants were divided into three groups: <30 ( = 4550, non-NAFLD), 30-59.9 ( = 2229, intermediate), and ≥60 ( = 1185, NAFLD). The incidence of stroke according to the degree of FLI was evaluated using the Cox proportional hazard model. (3) Results: During the 12-year follow-up period, 168 strokes occurred. A graded association between NAFLD and stroke incidence was observed, i.e., 1.7% ( = 76), 2.5% ( = 56), and 3.0% ( = 36) for non-NAFLD, intermediate, and NAFLD FLI groups, respectively. After adjusting for confounding variables and compared to the risk of stroke in the non-NAFLD group, the risk of stroke in the NAFLD group was the highest (hazard ratio [HR]: 1.98, 95% confidence interval [CI]: 1.17-3.34), followed by the risk of stroke in the intermediate group (HR: 1.41, 95% CI: 0.94-2.21) ( for trend < 0.001). However, the level of aspartate aminotransferase, alanine aminotransferase, or gamma-glutamyltransferase alone did not show any significant association with stroke. (4) Conclusions: This study demonstrated that the risk of stroke incidence gradually increased with the degree of FLI. Individuals with NAFLD should be properly counseled and monitored for risk for stroke.
(1) 背景:非酒精性脂肪性肝病(NAFLD)与多种心血管代谢疾病相关。然而,NAFLD 与中风之间的关联尚不清楚。本研究旨在揭示 NAFLD 与中风发病之间的关系。
(2) 方法:使用来自韩国前瞻性队列研究的数据,排除大量饮酒和有中风病史的参与者;因此,本研究纳入了 7964 名年龄在 40-69 岁的成年人。根据其脂肪肝指数(FLI),参与者被分为三组:<30(=4550,非 NAFLD)、30-59.9(=2229,中间)和≥60(=1185,NAFLD)。使用 Cox 比例风险模型评估根据 FLI 程度的中风发生率。
(3) 结果:在 12 年的随访期间,发生了 168 例中风。观察到 NAFLD 与中风发生率之间存在分级关联,即非 NAFLD、中间和 NAFLD FLI 组的中风发生率分别为 1.7%(=76)、2.5%(=56)和 3.0%(=36)。在校正混杂变量后,与非 NAFLD 组相比,NAFLD 组发生中风的风险最高(风险比[HR]:1.98,95%置信区间[CI]:1.17-3.34),其次是中间组(HR:1.41,95% CI:0.94-2.21)(趋势检验<0.001)。然而,天冬氨酸转氨酶、丙氨酸转氨酶或γ-谷氨酰转移酶的水平单独与中风无显著关联。
(4) 结论:本研究表明,随着 FLI 程度的增加,中风发病的风险逐渐增加。NAFLD 患者应进行适当的咨询和监测,以预防中风风险。